Method for diagnosing cancer by detecting GPC3

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9513292
APP PUB NO 20150132782A1
SERIAL NO

14579474

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is a method for diagnosing cancer by detecting a novel cancer marker. Cancer can be diagnosed by detecting soluble glypican 3 in a test sample.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PERSEUS PROTEOMICS INCTOKYO JAPAN TOKYO METROPOLIS

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aburatani, Hiroyuki Tokyo, JP 60 599
Ito, Yukio Tokyo, JP 143 1703
Midorikawa, Yutaka Tokyo, JP 9 75
Nakano, Kiyotaka Shizuoka, JP 122 3057
Ohizumi, Iwao Shizuoka, JP 12 67
Tokita, Susumu Tokyo, JP 13 100

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00